SCHEMBL7401253

SCHEMBL7401253

c1ccc(CN2CCN(c3ccnc4ccccc34)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.64
NCF1 P14598 2/20 0.64
ALDH1A1 P00352 3/20 0.60
LMNA P02545 3/20 0.60
KDM4E B2RXH2 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
NPSR1 Q6W5P4 1/20 0.60
ADRB2 P07550 1/20 0.58
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
HIF1A Q16665 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
ACHE P22303 1/20 0.53
SIGMAR1 Q99720 1/20 0.51
DRD4 P21917 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27666154 0.87 KCNH2 (0.54) KCNH2NCF1ALDH1A1LMNAKDM4E
SCHEMBL27470939 0.85 CYP3A4 (0.57) KCNH2NCF1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL27470403 0.85 CYP3A4 (0.71) KCNH2NCF1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL27666325 0.84 KCNH2 (0.73) KCNH2NCF1ADRB2SIGMAR1
SCHEMBL27666175 0.84 ALDH1A1 (0.63) KCNH2NCF1ALDH1A1LMNAKDM4E
SCHEMBL23362095 0.82 KCNH2 (0.64) KCNH2NCF1ALDH1A1LMNAKDM4E
SCHEMBL27549089 0.81 SRPK1 (0.51) KCNH2NCF1KDM4EADRB2ACHE
SCHEMBL27666271 0.81 SIGMAR1 (0.55) KCNH2NCF1MAPTSIGMAR1DRD4
SCHEMBL13438218 0.80 HRH3 (0.61) KCNH2ALDH1A1MAPTACHE
SCHEMBL27471403 0.79 RUNX1 (0.48) KCNH2NCF1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
CN-1169795-C Nitrogenous heterocyclic compounds Э�ͷ��͹�ҵ��ʽ���� 2004-10-06 CN disclosed
CN-1208404-A Nitrogenous heterocyclic compounds KYOWA HAKKO KOGYO KK (JP) 1999-02-17 CN disclosed
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed
US-5563141-A INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION ZENECA LIMITED (GB) 1996-10-08 US disclosed
EP-0690847-A1 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-10 EP disclosed
WO-1994022835-A2 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed